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Anti-LPS factor, which inhibits the endotoxin mediated coagulation system in the horseshoe crab, Tachyp- 
leus tridentatur, was found to lyse red blood cells sensitized with gram-negative bacterial LPS, but not to 
lyse unsensitized cells. This hemolysis occurred even at 0°C and was completed within 1 min. The binding 
of anti-US factor to LPS must be essential for the hemolysis, because free LPS inhibited the hemolytic 
action of anti-LPS factor. 
Horseshoe crab L~opoly~~c~i~ ~e~ly~~ Red blood cell 
1. INTRODUCTION 
Lipopolysaccharide (LPS) of gram-negative 
bacteria induces degranulation and blood coagula- 
tion of the amebocyte of the horseshoe crab. 
Amebocytes contain an LPS-mediated coagulation 
system consisting of several protein factors and an 
anticoagulant, named anti-LPS factor, which in- 
hibits the initial stage of the coagulation cascade 
activated by LPS [ 11. Anti-LPS factor has recently 
been purified and characterized asa basic protein 
with a molecular mass of 15 kDa [2,3]. As the 
other biological function, anti-LPS factor has anti- 
bacterial action against R-types of gram-negative 
bacteria [Z]. In the course of these studies, we 
found that anti-LPS factor exerted hemolytic ac- 
tion on the red blood cells sensitized with LPS. 
This paper describes characteristics of the anti- 
LPS factor-mediated hemolysis. 
Abbreviations: LPS, lipopolysaccharide; RBC, red 
blood cells 
2. MATERIALS AND METHODS 
Anti-LPS factor was isolated from the amebo- 
cyte lysate of Tachyplew tridentatus as in [I]. The 
fmal preparation was confirmed to show a single 
protein band on SDS-PAGE [4]. ~lrno~l~# min- 
nesota R595 LPS (Re type) was prepared by the 
phenol-chloroform-petroleum ether method [S]. 
LPS of S. minnesota 1114W (S-type) and E= coli 
0113 were hot-phenol extracts [6]. This LPS was 
dissolved in saline and sonicated at 20 kHz for 1 
min before use. Native polysaccharide of E. coli 
0113 was the O-antigenic polysaccharide moiety of 
E, coli 0113 LPS [7]. Red blood cells (RBS) were 
collected from human (O-type), chicken and horse 
blood with an addition of heparin. RBC were sen- 
sitized with the LPS derived from 5’. rni~~~o~a 
R595, 1114W and E. coli 0113. RBC were washed 
3 times with 50 mM T&-buffered saline (pH 7.2) 
and the concentration of the suspension was ad- 
justed to 2.5010. One ml of this suspension was 
mixed with 0.5 ml LPS solution of 1 n&ml and in- 
cubated at 37’C for 30 min. After the incubation, 
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Table 1 
Hemolytic activity of anti-LPS factor on RBC sensitized with LPS 
RBC sensitized with Dilution of anti-LPS factor 
2 4 8 16 32 64 128 256 512 1024 2048 Control 
S. minnesota R595 LPS 
(Human RBC) + + + + + + + + + + - 
S. minnesota 1114W LPS 
(Human RBC) + + + + + + + + + + + - 
S. minnesota 1114W LPS 
(Chicken RBC) + + + + + + + + + + - 
S. minnesota 1114W LPS 
(Horse RBC) + + + + + + + + + + + - 
E. coli 0113 LPS 
(Human RBC) + + + + + + + + + - - - 
None 
(Human RBC) - - - -___- - - - 
None 
(Chicken RBC) - - - - - - - - - - - 
None 
(Horse RBC) - - - - - - - - - - - 
Fifty ,ul of 0.5% RBC sensitized with LPS was mixed with 50 ~1 of a afold serial dilution of anti-LPS factor in a 
microtiter U-plate and incubated at 37°C for 30 min. The concentration of original solution of anti-LPS factor was 
2 mg/ml. + ,- hemolysis-positive; - , hemolysis-negative 
sensitized RBC were washed 3 times with the same 
buffer and finally the concentration of the suspen- 
sion was adjusted to 0.5%. The RBC sensitized 
with LPS were checked to be agglutinated by the 
antiserum to the bacterium from which LPS was 
derived. 
3. RESULTS 
3.1. Hemolytic activity of anti-LPS factor to the 
RBC sensitized with LPS 
The RBC sensitized with LPS were mixed with a 
2-fold serial dilution of anti-LPS factor and in- 
cubated at 37°C for 30 min. After the incubation, 
unexpected hemolysis was observed in the wells in 
which the sensitiz.ed RBC and anti-LPS factor were 
mixed (table 1). However, anti-LPS factor did not 
cause any hemolysis of unsensitized RBC. Horse 
and chicken RBC sensitized with LPS were also 
hemolysed in the presence of anti-LPS factor. In 
the case of human and horse RBC sensitized with 
S. minnesota R595 LPS, the minimum conceutra- 
tion of anti-LPS factor for hemolysis was as low as 
208 
0.98 /g/ml (table 1). Although the hemolysis oc- 
curred in spite of the species of RBC, human RBC 
sensitized with LPS were used in the following ex- 
periments. 
3.2. Inhibition of anti-LPS factor-mediated 
hemolysis by free LPS 
The sensitized RBC were added to the mixtures 
in which anti-LPS factor and a 2-fold serial dilu- 
tion of free LPS had been preincubated. As shown 
in table 2, S. minnesota R595 LPS completely in- 
hibited the hemolysis of RBC sensitized with S. 
minnesota R595 LPS as in the case of the S. min- 
nesota 1114W LPS system. But E. coli 0113 native 
polysaccharide did not inhibit the hemolysis of 
RBC sensitized with S. minnesota R595 LPS. The 
inhibitory effect of free LPS on the hemolysis 
caused by anti-LPS factor was also demonstrated 
by measuring hemoglobin liberated from the sen- 
sitized RBC in the presence of free LPS with 
various doses. As shown in fig.1, 0.31 pg E. coli 
0113 LPS could block the hemolysis of the RBC 
sensitized with S. minnesota R595 LPS caused by 
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Table 2 
Inhibition test of the hemolysis by free LPS 
Endotoxin mixed with 
anti-LPS factor 
Dilution of free. LPS 
4 8 16 32 64 128 256 512 1024 2048 Control 
S. minnesota R595 LPS - - - - - - - - -_ + 
S. minnesota 1114W LPS - - - - - - -___ + 
E. coli 0113 native 
polysaccharide + + + + + + + + + + + 
Twenty-five ~1 of a 2-fold serial dilution of free LPS was mixed with 25 pl anti-LPS factor (final concentration 20 
&ml); then 50 pl human RBC sensitized with the corresponding LPS was added. In the case of E. coli 0113 native 
polysaccharide, RBC sensitized with S. minnesota R595 LPS were used as target cells. The concentration of the original 
solution of free LPS was 1 mg/ml. + , hemolysis-positive; - , hemolysis-negative 
0.5 pg of anti-LPS factor. In this case, the hemo- 
lysis was found to be inhibited by the free LPS (E. 
coli 0113) differently from the LPS (S. minnesotu 
R595) used to sensitize RBC. 
3.3. Effect of temperature on the hemolysis 
The hemolysis of RBC sensitized with S. min- 
nesotu R595 LPS was carried out at 0°C and 37’C 
for 5 min with various concentrations of anti-LPS 
factor (fig.2). At 37”C, 0.625 /cg/ml anti-LPS fac- 
tor could complete the hemolysis. In the case of 
O”C, 2.5-5.Opg/ml anti-LPS factor was enough to 
complete the hemolysis. 
3.4. Time course of the hemolytic process 
The hemolytic process was chased by measuring 
the turbidity of the RBC sensitized with S. min- 
nesotu R595 LPS in the presence of anti-LPS fac- 
tor with various concentrations (3 1.2, 125 and 250 
ng/ml). As shown in fig.3, the hemolytic process 
was completed within1 min at 250 ng/ml. 
OOL- 
0 002 co8 on 125 5 
Free LP5 ( p9 ) 
Fig. 1. Neutralization of the hemolysis by free LPS. Fif- 
ty ~1 E. coli 0113 LPS with various concentrations were 
added to 50 ~1 anti-LPS factor (10 fig/ml) and then 100 
~1 RBC sensitized with S. minnesota R595 LPS. After in- 
cubation at 37°C for 5 min, each mixture was centri- 
fuged at 2000 rpm for 5 min. Liberated hemoglobin into 
supernatant was expressed as the absorbance at 412 nm. 
Final dose of anti-LPS factor was 0.5 pg. 
Anti LPS Factor 
( w/ml 1 
Fig. 2. Effect of temperature on the hemolysis. Reaction 
mixture containing 100 ~1 anti-LPS factor with various 
concentrations, lOOp1 RBC sensitized with S. minnesota 
R595 LPS was incubated for 5 min at 0°C (0) and 37°C 
(0). Unsensitized RBC was also incubated with anti- 
LPS factor at 37°C as control (A). After the incubation, 
800~1 of 50 mM Tris-buffered saline (pH 7.2) was add- 
ed. Liberated hemoglobin was measured after cen- 
trifugation. 
209 
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Time (min) 
Fig. 3. Time course of the hemolytic process. Reaction 
mixture containing 100 ~1 RBC sensitized with 8. min- 
nesotu R595 LPS, 50 ~1 anti-LPS factor with various 
concentrations - (0) 31.2 ng/ml, (0) 125 ng/ml, (A) 
250 ng/ml as final concentration - and 850~1 of 50 mM 
Tris-buffered saline @H 7.2) was made in the cell (light 
path, 1 cm) at 33°C. Turbidity (at 660 nm) was read at 
short intervals. 
4. DISCUSSION [31 
Anti-LPS factor, which has been identified to be 
an anticoagulant towards the LPS-mediated 
coagulation system in the horseshoe crab, T. 
tridentatus, was found to have a hemolytic func- 
tion with respect to the RBC sensitized with 
various LPS. Anti-LPS factor seems to bind to the 
LPS, especially lipid A, embedded in the RBC 
membrane in that the hemolysis was inhibited by 
S. minnesota R595 LPS (Re type LPS) but not by 
E. coli 0113 native polysaccharide. 
[41 
Since this hemolysis occurs even at O”C, and is 
completed within 1 min at 33”C, the hemolysis in- 
duced by anti-LPS factor is likely to be a direct 
hemolytic reaction specific for LPS rather than an 
enzymatic reaction. 
151 
161 
[71 
Binding of anti-LPS factor to lipid A has been 
suggested from the fact that it is antibacterial- 
specific for deep rough mutants of gram-negative 
bacteria and its activity is inhibited by the LPS of 
a deep rough mutant (unpublished). This binding 
must be essential for the hemolysis, the antibac- 
terial action and the anticoagulant action of anti- 
LPS factor. 
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